跳至主要内容
临床试验/NCT07098858
NCT07098858招募中不适用

The WiSE®-UP Study (The WiSE System Utilization & Performance Study)

EBR Systems, Inc.12 个研究点 分布在 1 个国家目标入组 320 人开始时间: 2025年11月3日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
320
试验地点
12
主要终点
Primary Safety

研究概览

简要总结

Observe to understand product performance, including patient safety, clinical outcomes, and CRT response information associated with the use of the market-released WiSE System

详细描述

The WiSE-UP Study is a prospective, real-world, observational study aimed at understanding acute and long-term product performance, including patient safety, clinical outcomes, and CRT response information associated with the use of the market-released WiSE System.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
22 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient or legally authorized representative can provide written authorization and/or consent per institution requirements.
  • Patient is intended to receive a WiSE System and passed the acoustic window screening
  • Patient who is, or will be, accessible for follow-up.
  • Participation is not excluded by local law.
  • Patient is not enrolled in a concurrent drug and/or device study that may confound the Registry results.
  • Patient life expectancy >1 year.

排除标准

  • 未提供

研究组 & 干预措施

Single-arm, prospective, multicenter, observational study.

Market-released WiSE System approved for commercial release with a market-released co-implanted system are eligible.

干预措施: The Wise System (Device)

结局指标

主要结局

Primary Safety

时间窗: 1, 6, 12, 24, 48 and 60 months

The primary outcome measure of the Study is the rate of serious adverse events (SAEs) at \< 30 days post implant related to the WiSE System and/or implant procedure.

次要结局

  • Efficacy 3(6 months)
  • Efficacy 1(1 month)
  • Efficacy 2(1 month)
  • Efficacy 4(6 months)
  • Efficacy 5(1, 6, 12, 24, 48 and 60 months)
  • Efficacy 6(1, 6, 12, 24, 48 and 60 months)
  • Efficacy 7(1, 6, 12, 24, 48 and 60 months)
  • Efficacy 8(6 and 12 months)
  • Efficacy 9(1, 6, 12, 24, 48 and 60 months)
  • Efficacy 10(1, 6, 12, 24, 48 and 60 months)
  • Efficacy 11(1, 6, 12, 24, 48 and 60 months)
  • Efficacy 10(1, 6, 12, 24, 48 and 60 months)
  • Efficacy 11(1, 6, 12, 24, 48 and 60 months)
  • Efficacy 1(1 month)
  • Efficacy 2(1 month)
  • Efficacy 3(6 months)
  • Efficacy 4(6 months)
  • Efficacy 5(1, 6, 12, 24, 48 and 60 months)
  • Efficacy 6(1, 6, 12, 24, 48 and 60 months)
  • Efficacy 7(1, 6, 12, 24, 48 and 60 months)
  • Efficacy 8(6 and 12 months)
  • Efficacy 9(1, 6, 12, 24, 48 and 60 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (12)

Loading locations...

相似试验